Fast-Tracked COVID-19 Vaccine — What Could Go Wrong?
Bill Gates — who illegally invests in the industries he gives charitable donations to and promotes a global public health agenda that benefits the companies he’s invested in — claims life cannot go back to normal until we can vaccinate the global population against COVID-19.1,2
And, according to The Rockefeller Foundation’s white paper,3 “National COVID-19 Testing Action Plan,” privacy concerns “must be set aside” so that the infection status of every individual can be accessed and validated before permission is given to entering schools, office buildings, places of work, airports, concert and sport venues and more.
We’re currently being told that we “must” forgo our civil liberties because we might spread a virus to a potentially vulnerable individual. To prevent deaths from occurring by people moving about freely, we’re told we have to stop living.
Yet every single flu season throughout history, people have moved about, spreading the infection around and facilitating the acquisition of natural herd immunity. Undoubtedly, most people who have ever left their house with a cold, stomach bug or other influenza at any point in the past, have unwittingly spread the infection to others, some of which may have ended up with a serious case of illness and some of which may ultimately have died from it.
There is simply no way to prevent such a chain of events in perpetuity. As noted by Attorney General William Barr in an April 21, 2020, interview with Hugh Hewitt,4 “impingements on liberty” were adopted “for the limited purpose of slowing down the spread, that is bending the curve. We didn’t adopt them as the comprehensive way of dealing with this disease.”
Indeed, giving up our civil liberties in an effort to prevent all future deaths from infectious disease is profoundly misguided, and will not work in the long run.
Still, people around the world are being effectively manipulated and brainwashed with carefully honed propaganda derived from massive behavioral surveillance, to put life on hold until there’s a vaccine. Of course, by then, vaccination will likely become mandatory for anyone who wants to return to regular life.
To pull off this global plan of “disease surveillance” (which will eventually be tied to digital finance and identification schemes that are also in the works), those advocating for a “new normal” need a vaccine, and they need it fast, while fears are still dominating the news.
Vaccine Makers Race to Create COVID-19 Vaccine
Safety testing for vaccines typically leaves much to be desired to begin with, but when it comes to fast-tracked pandemic vaccines, safety testing is accelerated and becomes even more inadequate. The COVID-19 vaccine may in fact be the most fast-tracked vaccine ever created in history, which necessitates the elimination of required safety testing steps, such as animal testing.5,6
May 5, 2020, The New York Times reported7 that Pfizer, in collaboration with BioNTech, was scheduled to begin human trials of a COVID-19 vaccine on May 11, 2020 in the U.S. If successful, the vaccine could be released under an FDA-approved Emergency Use Authorization (EUA)8 as early as September 2020 — an unheard-of timeframe for any vaccine development.
Other vaccine makers have announced vaccine candidates will be ready in September as well9 — far sooner than the original 18 months to two years that Gates, Fauci and other authorities initially predicted at the beginning of this pandemic.
April 23, 2020, a dozen healthy German volunteers, aged 18 to 55, received Pfizer’s vaccine candidate, known only as BNT162.10 That trial is expected to eventually be expanded to 200.
Why the elderly, who are the most vulnerable to COVID-19 complications, would be excluded is a question worth asking — especially in light of the paradoxical immune enhancement that coronavirus vaccines are known for. (l’ll cover that in a later section.)
The U.S. trial will include 360 healthy volunteers in the first stage, and as many as 8,000 in the second stage. Volunteers will be divided into four groups, each group receiving one of four variations of the vaccine. The trial is being conducted at New York University’s Grossman School of Medicine, the University of Maryland School of Medicine, the University of Rochester Medical Center and the Cincinnati Children’s Hospital Medical Ce
Article from LewRockwell